selonabant

DB18908InvestigationalSmall molecule

ANEB-001 is under investigation in clinical trial NCT05282797 (Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of CB1 Antagonist ANEB-001 in a THC Challenge Test).

Chemical structure of selonabant
Formula / weight
C22H24ClF3N2O2 · 440.89 g/mol (avg)
Also known as
1-AZETIDINECARBOXAMIDE, 3-((R)-(4-CHLOROPHENYL)(2-(TRIFLUOROMETHYL)PHENYL)METHOXY)-N-(1,1-DIMETHYLETHYL)- · 3-((R)-(4-CHLOROPHENYL)(2-(TRIFLUOROMETHYL)PHENYL)METHOXY)-N-(1,1-DIMETHYLETHYL)-1-AZETIDINECARBOXAMIDE
Code names
ANEB-001

Resolves to

Compound
UNII4RNU8C6XXWCAS791848-71-0ChEMBLCHEMBL5095165
Structure
InChIKeyBNLYOVHLLDBOFZ-LJQANCHMSA-NSMILESCC(C)(C)NC(=O)N1CC(C1)O[C@H](C1=CC=C(Cl)C=C1)C1=CC=CC=C1C(F)(F)F
Targets
P21554CNR1

What you can answer from here — as of October 28, 2025

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
2Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which drugs share a target with selonabant, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In